UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 96

Sortiert nach

Transaminasen

MMW Fortschritte der Medizin, 2021-05, Vol.163 (9), p.51-51

Zachoval, Reinhart

2021

Volltextzugriff (PDF)

Inhibitory phenotype of HBV-specific CD4+ T-cells is characterized by high PD-1 expression but absent coregulation of multiple inhibitory molecules

PloS one, 2014-08, Vol.9 (8), p.e105703-e105703

2014

Volltextzugriff (PDF)

Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort

PloS one, 2015-08, Vol.10 (8), p.e0135807-e0135807

2015

Volltextzugriff (PDF)

Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease

PloS one, 2013-03, Vol.8 (3), p.e58955-e58955

2013

Volltextzugriff (PDF)

Recurrence of hepatitis C virus after loss of virus-specific CD4 + T-cell response in acute hepatitis C

Gastroenterology (New York, N.Y. 1943), 1999-10, Vol.117 (4), p.933-941

1999

Volltextzugriff (PDF)

Hepatitis C Virus Infection and Injection Drug Users: Prevention, Risk Factors, and Treatment

Clinical infectious diseases, 2005-04, Vol.40 (Supplement-5), p.S330-S335

2005

Volltextzugriff (PDF)

YKL-40 and transient elastography, a powerful team to assess hepatic fibrosis

Scandinavian journal of gastroenterology, 2011-11, Vol.46 (11), p.1369-1380

2011

Volltextzugriff (PDF)

Nucleosomal DNA Fragments in Autoimmune Diseases

Annals of the New York Academy of Sciences, 2006-09, Vol.1075 (1), p.318-327

2006

Volltextzugriff (PDF)

Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection

Hepatology (Baltimore, Md.), 2005-03, Vol.41 (3), p.643-651

2005

Volltextzugriff (PDF)

Chronic Hepatitis C - Therapeutic Options in 2016

MMW Fortschritte der Medizin, 2016-06, Vol.158 Suppl 1, p.54-57

2016

Volltextzugriff (PDF)

Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study

Journal of hepatology, 2017-11, Vol.67 (5), p.918-924

2017

Volltextzugriff (PDF)

Symptoms and Occurrence of Hepatitis E in Solid-Organ Recipients: A Single-Center Experience of the Last Five Years: PUB292

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.847-847

2021

Volltextzugriff (PDF)

Aktuelle Therapieoptionen bei chronischer Hepatitis C

MMW Fortschritte der Medizin, 2016-06, Vol.158 (Suppl 2), p.54-58

2016

Volltextzugriff (PDF)

Serum cortisol/cortisone ratio after Synacthen stimulation

Clinical biochemistry, 2001-07, Vol.34 (5), p.421-425

2001

Volltextzugriff (PDF)

Intrahepatic diffuse periportal enhancement patterns on hepatobiliary phase gadoxetate disodium-enhanced liver MR images: Do they correspond to periportal hyperintense patterns on T2-weighted images?

Medicine (Baltimore), 2019-03, Vol.98 (11), p.e14784-e14784

2019

Volltextzugriff (PDF)

Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction

The Journal of experimental medicine, 2014-09, Vol.211 (10), p.2047-2059

2014

Volltextzugriff (PDF)

The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus‐specific CD8+ T‐cell function

Hepatology (Baltimore, Md.), 2010-12, Vol.52 (6), p.1934-1947

2010

Volltextzugriff (PDF)

HEPATITIS B VACCINATION: HOW LONG DOES PROTECTION LAST?

The Lancet (British edition), 1984-08, Vol.324 (8400), p.458-458

1984

Volltextzugriff (PDF)

Prediction of treatment outcome in patients with chronic hepatitis C: Significance of baseline parameters and viral dynamics during therapy

Hepatology (Baltimore, Md.), 2003-03, Vol.37 (3), p.600-609

2003

Volltextzugriff (PDF)

Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance

Gastroenterology (New York, N.Y. 1943), 2003-07, Vol.125 (1), p.80-88

2003

Volltextzugriff (PDF)

Inhibitory Molecules That Regulate Expansion and Restoration of HCV-Specific CD4+ T Cells in Patients With Chronic Infection

Gastroenterology (New York, N.Y. 1943), 2011-10, Vol.141 (4), p.1422-1431.e6

2011

Volltextzugriff (PDF)

Non-invasive assessment of liver changes in Eisenmenger patients

International journal of cardiology, 2017-12, Vol.249, p.140-144

2017

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(88)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(61)
Science & Technology
(60)
Life Sciences & Biomedicine
(56)
Male
(41)
Female
(40)
Middle Aged
(39)
Adult
(38)
Biological And Medical Sciences
(34)
Medical Sciences
(29)
Infectious Diseases
(24)
Human Viral Diseases
(23)
Viral Diseases
(23)
Viral Hepatitis
(23)
Gastroenterology & Hepatology
(22)
Aged
(16)
Hepatitis C - Immunology
(15)
Hepacivirus - Immunology
(14)
Cd4-Positive T-Lymphocytes - Immunology
(13)
Hepacivirus - Genetics
(13)
Hepatitis C Virus
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Transaminasen

Inhibitory phenotype of HBV-specific CD4+ T-cells is characterized by high PD-1 expression but absent coregulation of multiple inhibitory molecules

Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort

Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease

Recurrence of hepatitis C virus after loss of virus-specific CD4 + T-cell response in acute hepatitis C

Hepatitis C Virus Infection and Injection Drug Users: Prevention, Risk Factors, and Treatment

YKL-40 and transient elastography, a powerful team to assess hepatic fibrosis

Nucleosomal DNA Fragments in Autoimmune Diseases

Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection

Chronic Hepatitis C - Therapeutic Options in 2016

Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study

Symptoms and Occurrence of Hepatitis E in Solid-Organ Recipients: A Single-Center Experience of the Last Five Years: PUB292

A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B

Aktuelle Therapieoptionen bei chronischer Hepatitis C

Serum cortisol/cortisone ratio after Synacthen stimulation

Intrahepatic diffuse periportal enhancement patterns on hepatobiliary phase gadoxetate disodium-enhanced liver MR images: Do they correspond to periportal hyperintense patterns on T2-weighted images?

Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction

The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus‐specific CD8+ T‐cell function

TOP-110 - Increasing functional cure rate beyond 96 weeks after discontinuation of nucleos (t)ide analogue treatment in HBeAg-negative chronic hepatitis B: follow-up of the stop-NUC trial

Increasing functional cure rate beyond 96 weeks after discontinuation of nucleos (t)ide analogue treatment in HBeAg-negative chronic hepatitis B: follow-up of the stop-NUC trial

HEPATITIS B VACCINATION: HOW LONG DOES PROTECTION LAST?

Prediction of treatment outcome in patients with chronic hepatitis C: Significance of baseline parameters and viral dynamics during therapy

Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance

Inhibitory Molecules That Regulate Expansion and Restoration of HCV-Specific CD4+ T Cells in Patients With Chronic Infection

Non-invasive assessment of liver changes in Eisenmenger patients

Suchergebnisse filtern